VFA
SZYM

Virtus Fund Advisers’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Virtus Fund Advisers’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,483
Closed -$76K – 2542
2014
Q2 		$76K Buy
+6,483
New +$69.1K ﹤0.01% 1593

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T
Tahithromos New York $71.9M AUM 0.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Virtus Fund Advisers's SZYM Position: Q3 2014 in Review

Virtus Fund Advisers sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q3 2014, closing a stake of 6,483 shares — an estimated $76K sold.

Virtus Fund Advisers first reported a position in SZYM in Q2 2014 and held it in 1 quarter. The position peaked at $76K in Q2 2014. 120 funds tracked by Wall St. Rank hold SZYM as of Q3 2014.

  • Virtus Fund Advisers reported no remaining SOLAZYME INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 6,483 SOLAZYME INC COM STK (DE) shares in Q3 2014, an estimated $76K.
  • Virtus Fund Advisers first reported a position in SOLAZYME INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's SOLAZYME INC COM STK (DE) position peaked at $76K in Q2 2014.
  • 120 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.